CNS Drugs Take 20% Longer to Develop and 38% Longer to Approve vs. Non-CNS Drugs, According to the Tufts Center for the Study of ...
BOSTON, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Developing drugs to treat central nervous system (CNS) disorders on average required 20% more time than other drugs that won marketing approval in the United States from 2000 through 2017, and took 38% longer to …